0001127602-23-002332.txt : 20230126
0001127602-23-002332.hdr.sgml : 20230126
20230126173009
ACCESSION NUMBER: 0001127602-23-002332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221228
FILED AS OF DATE: 20230126
DATE AS OF CHANGE: 20230126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACKAY GEOFFREY
CENTRAL INDEX KEY: 0001741849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 23558789
MAIL ADDRESS:
STREET 1: C/O AVROBIO, INC.
STREET 2: ONE KENDALL SQ, BLDG. 300, STE. 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVROBIO, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617.914.8420
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-12-28
0001681087
AVROBIO, Inc.
AVRO
0001741849
MACKAY GEOFFREY
C/O AVROBIO, INC.
100 TECHNOLOGY SQUARE, 6TH FLOOR
CAMBRIDGE
MA
02139
1
1
President & CEO
Common Stock
2022-12-28
5
G
0
E
245123
0
D
142013
D
Common Stock
2022-12-28
5
G
0
E
245123
0
A
445123
I
By The Geoff R. MacKay Irrevocable Trust
Common Stock
2023-01-24
4
M
0
45999
.91
A
188012
D
Common Stock
72604
I
By daughter of reporting person
Common Stock
72604
I
By son of reporting person
Stock Option (Right to Buy)
.91
2023-01-24
4
M
0
45999
0
D
2027-06-12
Common Stock
45999
0
D
This transaction was a bona fide gift of common stock to The Geoff R. MacKay Irrevocable Trust. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The shares were previously held in a custodial account for the Reporting Person's son, established pursuant to the Uniform Transfers to Minors Act ("UTMA"), for which the Reporting Person served as custodian. The shares have since been distributed to the Reporting Person's son, as required by the terms of the account upon the son attaining the age of 21. 54,453 shares were subsequently transferred to the Mac C. MacKay Irrevocable Trust on December 30, 2022.
25% of the shares vested on June 13, 2018, and the remaining 75% vested in equal monthly installments thereafter over a three-year period.
/s/ Steven Avruch, Attorney-in-Fact for Geoffrey MacKay
2023-01-26